Guangzhou KingCreate Biotechnology Co., Ltd.
PrivateLast Round
Series C
Aug 1, 2023
Total Funding Raised
$15.3M
Company Overview
Guangzhou KingCreate Biotechnology Co., Ltd. is a biotechnology company that develops precision medicine solutions, including genetic sequencers, diagnostic instruments, and genetic testing kits for clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guangzhou KingCreate Biotechnology Co., Ltd. Comparables
Compare Guangzhou KingCreate Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hangzhou MatriDx Biotechnology Co., Ltd. | 89% | |
| 金匙医学 | 86% | |
| Vision Medicals | 84% |
Guangzhou KingCreate Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 1, 2023 | ||||
| Series B | Dec 25, 2020 | ||||
| Series A | Jul 1, 2019 |
Guangzhou KingCreate Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Capital | Series A, Series C, Series B |
| E Fund Management | Series B |
| Shiyu Capital | Series A |
| Peakview Capital | Series C |
| China Development Bank Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2023
Led by Peakview Capital with participation from Legend Capital.
- Dec 25, 2020
$15.3M round led by E Fund Management.
Guangzhou KingCreate Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Guangzhou KingCreate Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Guangzhou KingCreate Biotechnology Co., Ltd. a public or private company?
Guangzhou KingCreate Biotechnology Co., Ltd. is a private company.
What is the current stock price of Guangzhou KingCreate Biotechnology Co., Ltd.?
Guangzhou KingCreate Biotechnology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Guangzhou KingCreate Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Guangzhou KingCreate Biotechnology Co., Ltd. is not publicly available.
Can I buy Guangzhou KingCreate Biotechnology Co., Ltd. stock?
Guangzhou KingCreate Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Guangzhou KingCreate Biotechnology Co., Ltd.'s last funding round?
Guangzhou KingCreate Biotechnology Co., Ltd.'s most recent funding round was Series C on August 1, 2023.
Who are the main investors in Guangzhou KingCreate Biotechnology Co., Ltd.?
Key investors in Guangzhou KingCreate Biotechnology Co., Ltd. include E Fund Management, Peakview Capital.
Will Guangzhou KingCreate Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Guangzhou KingCreate Biotechnology Co., Ltd..
How can I track Guangzhou KingCreate Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Guangzhou KingCreate Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.